secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oruka Therapeutics, Inc. (ORKA)
CIK:        0000907654
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0000950170-24-035373
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ARCA biopharma extends headquarters lease through September 2024 at increased rent
--------------------------------------------------------------------------------

- Lease extended 6 months to Sept 30, 2024; base rent raised to $8,206.42/month from April 1.
- After extension, month-to-month tenancy at 125% of Sept 2024 base rent if tenant remains.
- Company must provide 60-day vacate notice; landlord may market space during extension period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/907654/000095017024035373/0000950170-24-035373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/907654/000095017024035373/abio-20240319.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-035373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer